Information regarding the inaccurate disclosure in Biotage/Active Biotech
On March 11, Investor formally disclosed the purchase of shares in Active Biotech, as previously announced on March 6. The disclosure was carried out by law firm Roschier. Of yet to be determined reasons, the disclosure which was sent out at 13:42 pm, was wrongly headlined as Biotage. The ISIN-code, describing which stock the disclosure refers to was correct (Active Biotech), however the company name was incorrect. The FSA(Finansinspektionen) sent out a correction at 13:53 pm where the company name had been corrected to Active Biotech. We are currently, together with Roschier, investigating how this error could occur and we have requested further information from the FSA regarding this matter. Until this issue has been resolved, we will handle all disclosures manually.